Biora Therapeutics

BIOR

0.22000.00% ( 0.0000 )

Delay Closed: Sep 25, 16:00:00 (EDT)

Current Valuation

--P/E

Stock price--

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

021426384

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GILDUSGilead Sciences	-60.73x	150.60%	$196.77B
MRNAUSModerna	-25.19x	17.00%	$79.39B
CSLLYUSCSL Limited	-25.37x	--	$65.44B
NTRAUSNatera	-303.43x	5.57%	$58.36B
RVMDUSRevolution Medicines	-22.29x	61.94%	$39.42B
ROIVUSRoivant Sciences	-97.80x	146.69%	$26.04B
BNTXUSBioNTech SE	-11.16x	18.90%	$21.82B
INSMUSInsmed	-23.28x	75.01%	$20.38B
BBIOUSBridgebio Pharma	-19.26x	27.56%	$13.32B
SMMTUSSummit Therapeutics	-13.51x	19.85%	$11.57B
MDGLUSMadrigal Pharma	-31.11x	51.30%	$10.11B
PCVXUSVaxcyte	-8.87x	47.91%	$9.44B
TWSTUSTwist Bioscience	-69.94x	28.63%	$9.56B
KYMRUSKymera Therapeutics	-31.87x	5.24%	$9.55B
IBRXUSImmunityBio	-8.34x	151.32%	$8.28B
CYTKUSCytokinetics	-9.44x	6.85%	$8.44B
ARWRUSArrowHead Pharma	-26.04x	35,923.70%	$8.33B
SYREUSSpyre Therapeutics	-54.54x	45.60%	$8.19B
ABVXUSAbivax SA	-16.21x	22.99%	$7.54B
IONSUSIonis Pharma	-12.77x	49.51%	$7.22B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.